{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:49:04Z","timestamp":1789868944348,"version":"4.0.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>\n              <jats:italic>Staphylococcus aureus<\/jats:italic>, one of the most frequently isolated pathogens in both hospitals and the community, has been particularly efficient at developing resistance to antimicrobial agents. In developed countries, as methicillin-resistant <jats:italic>S. aureus<\/jats:italic> (MRSA) has prevailed and, furthermore, as <jats:italic>S. aureus<\/jats:italic> with reduced susceptibility to vancomycin has emerged, the therapeutic options for the treatment of <jats:italic>S. aureus<\/jats:italic> infections have become limited. In developing countries and especially African countries very little is known concerning the resistance of <jats:italic>S. aureus<\/jats:italic> to antibiotics. In Madagascar no data exist concerning this resistance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To update the current status of antibiotic resistance of <jats:italic>S. aureus<\/jats:italic> in Antananarivo, Madagascar.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Clinical <jats:italic>S. aureus<\/jats:italic> isolates were collected from patients at the Institut Pasteur of Madagascar from January 2001 to December 2005. Susceptibility tests with 18 antibiotics were performed by the disk diffusion method.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among a total of 574 isolates, 506 were from community-acquired infections and 68 from nosocomial infections. There was no significant difference in the methicillin resistance rate between community-acquired strains (33 of 506; 6.5%) and nosocomial strains (3 of 68, 4.4%). Many MRSA isolates were resistant to multiple classes of antibiotics. Resistance to tetracyclin, trimethoprim-sulfamethoxazole and erythromycin was more common. Among MRSA isolates resistance rates to rifampicin, fusidic acid, gentamicin and ciprofloxacin were lower than that observed with other drugs easily available in Madagascar. No isolates were resistant to glycopeptides.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The rate of methicillin-resistant <jats:italic>S. aureus<\/jats:italic> is not different between community-acquired and nosocomial infections and is still rather low in Madagascar.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-0711-6-5","type":"journal-article","created":{"date-parts":[[2007,5,23]],"date-time":"2007-05-23T23:33:18Z","timestamp":1179963198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar"],"prefix":"10.1186","volume":"6","author":[{"given":"Fr\u00e9d\u00e9rique","family":"Randrianirina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisoa","family":"Ratsima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Carod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Combe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Grosjean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Talarmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,23]]},"reference":[{"key":"104_CR1","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0732-8893(98)00162-X","volume":"34","author":"GV Doern","year":"1999","unstructured":"Doern GV, Jones RN, Pfaller MA, Kugler KC, Beach ML: Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Diagn Microbiol Infect Dis. 1999, 34: 65-72. 10.1016\/S0732-8893(98)00162-X","journal-title":"Diagn Microbiol Infect Dis"},{"key":"104_CR2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0924-8579(03)00154-7","volume":"22","author":"ME Jones","year":"2003","unstructured":"Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Nathwani D: Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. Int J Antimicrob Agents. 2003, 22: 406-419. 10.1016\/S0924-8579(03)00154-7","journal-title":"Int J Antimicrob Agents"},{"key":"104_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S0732-8893(98)00124-2","volume":"32","author":"HS Sader","year":"1998","unstructured":"Sader HS, Jones RN, Gales AC, Winokur P, Kugler KC, Pfaller MA, Doern GV: Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). Diagn Microbiol Infect Dis. 1998, 32: 289-301. 10.1016\/S0732-8893(98)00124-2","journal-title":"Diagn Microbiol Infect Dis"},{"key":"104_CR4","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","volume":"1","author":"MP Jevons","year":"1961","unstructured":"Jevons MP: Celbenin-resistant staphylococci. Br Med J. 1961, 1: 124-126.","journal-title":"Br Med J"},{"key":"104_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.micro.56.012302.160806","volume":"56","author":"TR Walsh","year":"2002","unstructured":"Walsh TR, Howe RA: The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Annu Rev Microbiol. 2002, 56: 657-675. 10.1146\/annurev.micro.56.012302.160806","journal-title":"Annu Rev Microbiol"},{"key":"104_CR6","first-page":"259","volume":"59","author":"JW Decousser","year":"1999","unstructured":"Decousser JW, Pfister P, Xueref X, Rakoto-Alson O, Roux JF: R\u00e9sistances acquises auxantibiotiques \u00e0 Madagascar: premi\u00e8re \u00e9valuation. Med Trop. 1999, 59: 259-265.","journal-title":"Med Trop"},{"key":"104_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/jac\/dkl466","volume":"59","author":"F Randrianirina","year":"2007","unstructured":"Randrianirina F, Soares JL, Carod JF, Ratsima E, Thonnier V, Combe P, Grosjean P, Talarmin A: Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in Antananarivo, Madagascar. J Antimicrob Chemother. 2007, 59: 309-312. 10.1093\/jac\/dkl466","journal-title":"J Antimicrob Chemother"},{"key":"104_CR8","volume-title":"Recommandations 2007","author":"Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie","year":"2007","unstructured":"Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie: Recommandations 2007. 2007, R Skov, R Smyth, AR Larsen, A Bolmstrom, A Karlsson, K Mills, N Frimodt-Moller, , SFM, Paris, France,"},{"key":"104_CR9","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1128\/JCM.01411-06","volume":"44","author":"G Kahlmeter","year":"2006","unstructured":"Kahlmeter G: Phenotypic detection of methicillin resistance in Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar. J Clin Microbiol. 2006, 44: 4395-4399. 10.1128\/JCM.01411-06","journal-title":"J Clin Microbiol"},{"key":"104_CR10","volume-title":"15th informational supplement M100-S15","author":"Clinical and Laboratory Standards Institute","year":"2005","unstructured":"Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing. 15th informational supplement M100-S15. 2005, Clinical and Laboratory Standards Institute, Wayne, PA,"},{"issue":"Suppl 2","key":"104_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1086\/320184","volume":"32","author":"DJ Diekema","year":"2001","unstructured":"Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, : Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997\u20131999. Clin Infect Dis. 2001, 32 (Suppl 2): 114-132. 10.1086\/320184.","journal-title":"Clin Infect Dis"},{"key":"104_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1046\/j.1469-0691.2003.00531.x","volume":"9","author":"C Kesah","year":"2003","unstructured":"Kesah C, Ben Redjeb S, Odugbemi TO, Boye CS, Dosso M, Ndinya Achola JO, Koulla-Shiro S, Benbachir M, Rahal K, Borg M: Prevalence of methicillin-resistant Staphylococcus aureus in eight African hospitals and Malta. Clin Microbiol Infect. 2003, 9: 153-156. 10.1046\/j.1469-0691.2003.00531.x","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"104_CR13","first-page":"74","volume":"24","author":"GA Ayliffe","year":"2003","unstructured":"Ayliffe GA: The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2003, 24 (Suppl 1): 74-79.","journal-title":"Clin Infect Dis"},{"key":"104_CR14","first-page":"258","volume":"42","author":"CL Obi","year":"1996","unstructured":"Obi CL, Iyiegbuniwe AE, Olukoya DK, Babalola C, Igumbor EO, Okonta AA: Antibiograms and plasmids of Staphylococcus aureus and coagulase negative staphylococci isolated from different clinical sources. Cent Afr J Med. 1996, 42: 258-261.","journal-title":"Cent Afr J Med"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-0711-6-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T22:40:35Z","timestamp":1630449635000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/1476-0711-6-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,23]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["104"],"URL":"https:\/\/doi.org\/10.1186\/1476-0711-6-5","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,23]]},"assertion":[{"value":"15 March 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}